Illumina Inc - ILMN Net Assets per Single Share

Graphic logo of Illumina Inc (ILMN)

Illumina, Inc. (ILMN) has stabilized its workforce by focusing on attracting a new generation of chemists. Despite pressure from tech startups disrupting its former monopoly in DNA analysis, the company maintains its position. The book value per share curve on the GURU.Markets daily chart shows that the current value is 18.80, confirming the reliability of global supply chains and the high profitability of the equipment.

Illumina Inc (ILMN) - Accounting Value per Share from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for illumina.com (ILMN)

- price and consensus price forecast:
Price Chart Illumina Corp|ILMN - Consensus Target
- market capitalization data:
Market Value Illumina, Inc.|ILMN - Business Value
- book capitalization data:
Net Assets per Single Share Illumina|ILMN - Company Net Assets|Market Capitalization to Book Value Ratio illumina.com|ILMN - Company Assets
- debt and liquidity data:
Total Debt to Capital Illumina, Inc.|ILMN - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Illumina|ILMN - Company Aggregate Debts|Debt to Book Capitalization Ratio Illumina, Inc.|ILMN - Company Long-Term Indebtedness|Company Short-Term Debts Illumina
Fundamental company valuation:Illumina, Inc.
Manufactured product of illumina.com

To protect capital during periods of volatility, it is critical for investors to track the actual net asset value. This metric is calculated as the difference between total equity and all business liabilities. Analyzing the aggregate balance sheet value of a share allows for the identification of hidden trends in fundamental valuation. The growth of this vector confirms the stability of the financial foundation of Illumina, Inc. (ILMN). The stability of this metric is supported by cost optimization through the regulated outsourcing of sequencer components.

Competitors of Illumina, Inc. (ILMN)

A: Net Assets per Single Share|DGX: Accounting Value per Share|Net Assets per Single Share Exact Sciences|RVTY (revvity.com) - Equity per Share|Net Assets per Single Share BIO|Accounting Value per Share Anbio Biotechnology Ltd|Sterigenics - Book Value per Share|Net Asset Value per Share QuidelOrtho Inc. (QDEL)|OPK - Book Value per Share|Equity per Share CareDx Health CDNA|Maravai LifeSciences Holdings, Inc. - Book Value per Share|FLGT: Book Value per Share|Net Assets per Single Share Fluidigm|Cytek Corp (CTKB) - Equity per Share|OSUR (OraSure Technologies) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share Biomerica Inc|CDIO (Cardio Diagnostics) - Book Value per Share|Net Assets per Share VRAX (viraxbiolabs.com)|Net Assets per Single Share Bluejay Diagnostics, Inc. BJDX|Aspira Women's Health, Inc. - Net Assets per Single Share|AXDX - Net Assets per Single Share|Centogene N.V. (CNTG) - Net Assets per Single Share|ENZ: Accounting Value per Share|FRES (Fresh2 Group) - Book Value per Share|Net Assets per Single Share GENE|Accounting Value per Share 23andMe Holding Co|PMD (Psychemedics Corp) - Book Value per Share